Drugs Used in Circadian Sleep-Wake Rhythm Disturbances.
Study Goal
The researchers aimed to review melatonin's circadian phase-shifting and sleep-enhancing properties, along with its safety concerns and clinical guidelines for treating circadian rhythm disorders.
Results Summary
The study found that melatonin and melatonin receptor agonists have significant circadian phase-shifting and sleep-enhancing effects, with practical treatment considerations discussed. Safety concerns were noted but not detailed.
Population
Not specified (general review of clinical guidelines and properties).
Effective Dosage
Not specified (mentions "recommended use" but no specific dosage).
Duration
Not specified.
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
melatonin | increase | circadian phase | - | - | circadian phase shifting properties | #1 |
melatonin | increase | sleep | - | - | sleep-enhancing properties | #2 |
other melatonin receptor agonists | increase | circadian phase | - | - | circadian phase shifting properties | #3 |
other melatonin receptor agonists | increase | sleep | - | - | sleep-enhancing properties | #4 |
This article focuses on melatonin and other melatonin receptor agonists, and specifically their circadian phase shifting and sleep-enhancing properties. The circadian system and circadian rhythm sleep-wake disorders are briefly reviewed, followed by a summary of the circadian phase shifting, sleep-enhancing properties, and possible safety concerns associated with melatonin and other melatonin receptor agonists. The recommended use of melatonin, including dose and timing, in the latest American Academy of Sleep Medicine Clinical Practice Guidelines for the treatment of intrinsic circadian rhythm disorders is also reviewed. Lastly, the practical aspects of treatment and consideration of clinical treatment outcomes are discussed.